Sign Up or Login to Continue

In order to view live auctions, browse company order books, auction instructions and price history, we need to confirm your investor or shareholder status.

Please Login or Sign Up
to continue

HeiQ plc

Company Name:HeiQ plc Minimum fundraise:£0.00* High Share Price Bid:£0.00

Business Sector:Chemicals Total Funds Bid to Date:- Low Share Price Bid:£0.00

Auction period:19 Nov 2024 - 18 Dec 2024 Indicative Share Price:0.00 Average Share Price Bid:£0.00**

Company Details Below

*The company will accept oversubscription.

**In the event of significant oversubscription, shares will be allocated to bids at the average price and above.

NOTE: ASSET MATCH HAS NEGOTIATED AN “ASSET MATCH INVESTOR BONUS” FOR INVESTORS IN THIS TRANSACTION. SEE THE “OVERVIEW” SECTION BELOW FOR DETAILS.

PLACE MY BID

Bid Name

Select how your name appears (Tick one of the boxes to select):

Openly

Confidentially

Make Bid

Enter your bid for shares:

Number of shares bidding for

(Enter total in numbers, i.e. 100000 or 500000 or 1000000, etc)

Bid price for share (US$)

(Enter total in numbers with two decimal points, i.e. 1.50 or 2.00, etc)

Total funds bid (US$)

(Please note, the minimum funds bid is US$ 10,000)

CONFIRMATION:

I confirm that:

I am a sophisticated or licenced investor according to this definition. I am legally entitled to place this bid. I am not contravening any laws of my country by placing this bid. I indemnify Asset Match, Webtel.mobi (Holdings) Limited and all of their officers and members or persons associated with them or with this process in the event that either of these aforementioned confirmations are not correct. I understand that I may amend this bid at any time. I understand that this bid is not a formal and binding commitment at this time but rather an expression of interest and intent, and that only at the end of the bidding process when the final share price is established will I be contacted to confirm my interest to proceed, and to thereafter make a formal application to purchase shares, and that only once I have elected to make – and have made, and signed, at my own discretion – a formal application to purchase shares will my expression of interest and intent become a formal and binding commitment. I confirm that I understand that Asset match may contact me to confirm the veracity of my bid, my bona finds and my intentions, and my bona fides, if I submit a bid that is clearly contrary to the indicative level of bids on the platform or contrary to the generally perceived value of the shares. By ticking this box I indicate confirmation that I have read, understand, agree with and confirm all of the aspects covered in this “Confirmation” paragraph:

Need help?
+44 (0) 207 248 2788

back

HeiQ plc

Following HeiQ's decision to delist from the Main Market of the London Stock Exchange, the company have appointed Asset Match to provide a Secondary Market Dealing Facility in the Ordinary Shares.

If you would like to receive further information and subsequent auction details then please register and add HeiQ to your watch list.

An order book will appear here as and when buy/sell orders are received.

Please direct any queries to dealing@assetmatch.com or Tel. 020 7248 2788.

Interested in HeiQ plc?
Register or log in to participate, create a watchlist, or set reminder

Company info

Founded in 2005, HeiQ plc is a Swiss-based international company that is a global leader in biotech ingredients and specialty chemicals for diverse applications such as textiles, flooring, building materials, glass, plastics, probiotic cleaning, cosmetics, and more. Working with more than 1000 partners in over 60 countries, our goal is to infuse ordinary products with extraordinary qualities, offering our co-creation partners sustainable and disruptive solutions across industries.

Our business model focuses on the commercialization of existing and as well as the incubation of new technologies, driving shareholder value through sales growth, entry into lucrative markets, and disruptive innovation. Our business model consists of three distinct platform technology ventures, being HeiQ AeoniQ™, HeiQ Xpectra, and HeiQ GrapheneX, and two growth-orientated commercialized business units financing our ventures, being HeiQ Life Sciences (probiotic industrial biotech) and HeiQ Advanced Materials.

We have a robust track record of innovation, with over 200 technologies developed in partnership with 300 major brands, including Hanes, Burberry, HUGO BOSS, Lycra, Zara, Itochu, Bosch Siemens, Ecolab, Woellner, Americhem, Lixil, and many more. Our global team comprises 230 professionals from 30 nationalities across five continents. We're committed to shaping a future where everyday products drive positive change, one innovation at a time.

www.heiq.com

Auction Details

The Ordinary Shares of HeiQ plc were admitted to trading on Asset Match on 19 November 2024 at a price of 4.5 pence per share (being the last traded price on the Main Market of the London Stock Exchange).

Auctions are to be held Monthly and close at 3pm on the last Wednesday of each month (unless stated otherwise).

The tick size for this company is 0.25pence per share.

Participants can send orders via their existing broker or directly to shareDeal active. Further details can be found by clicking on the "Auction instructions" section below.

Auction instructions

To buy and sell shares in this company via Asset Match Private Market, you will need to use a stockbroker.

- shareDeal active

If you are a UK resident, our main broker and settlement agent for all CREST eligible companies on the AM Private Market is shareDeal active.

shareDeal active provide a competitively priced service for both certified and non-certified transactions. You can open an account online or by post using the form provided.

Alternatively, if you already have an account with shareDeal active and wish to place an order please contact the Dealing desk directly on 01892 510515 or deal online.

To sell a share certificate, the easiest way to trade is to set up a shareDeal active account online and once open post your share certificate with a completed CREST transfer form. Alternatively, you can open an account by post using the Asset Match Certificated Sale Pack which includes everything you will need.

It generally takes 5-7 days for your account to be open and shares available for trading.

- Already have a stockbroker

Over 60 UK brokers regularly trade and are set up to deal on our platform. These brokers can submit your instructions to shareDeal active on your behalf*.

Please note that not all brokers are able to deal in unquoted shares so contact us to confirm whether your broker is able to trade.

- Overseas

If you are based overseas and are interested in participating then please contact us directly by emailing dealing@assetmatch.com or by calling 020 7248 2788.

When buying and selling shares, please note that the Asset Match levy of 3% applies, with a minimum charge of £20 per trade (*additional fees may apply).

For more information on how the auction works then please click here.

Key People

Robert Van De Kerkhof Non-Executive Director & Chair

Robert Van de Kerkhof brings over three decades of comprehensive experience in general management and sustainability leadership to his role as Chairman of HeiQ’s Board of Directors. With a profound understanding of the textiles industry, particularly in cellulosic fiber technology, Robert is a visionary leader committed to driving sustainable transformation. Robert has demonstrated his dedication to advancing sustainable practices within the industry. His profound insights and strategic acumen have been instrumental in his role as Chief Sustainability Officer and Board Member of Lenzing AG, a position he held until December 31, 2023. Robert has held prominent positions, including President of the Austrian Fiber Institute, President and Board Member of CIRFS – the European Man-made Fibres Association, and Chairman of the ReHubs Business Council for Euratex. As Chairman of HeiQ’s Board of Directors, Robert Van de Kerkhof is poised to guide the company toward a future where innovation and sustainability converge to create a positive impact on both the industry and the planet.

Carlo Centonze Co-Founder & CEO of HeiQ; Executive Director

Carlo studied Environmental Sciences and Forest Engineering (MSc) at the Swiss Federal Institute of Technology, ETH Zurich. He earned his Executive MBA at the University of St.Gallen (HSG). After his service as an army pilot, he started his professional career as co-founder of the ETH spin-off, myclimate, a non-profit organization and prominent provider of carbon offsetting measures. Since 2004, Carlo has served HeiQ as co-founder and CEO, developing the firm from a two-employee company to an over 200-employee company. He also serves as chairman of ECSA Group, a 108-year-old Swiss chemical and energy distributor with an annual consolidated turnover of over US$300 million, and is a member of the executive board of Science Industries, the Swiss association of the pharmaceutical, biotech, and chemical industries.

Xaver Hangartner CFO of HEiQ; Executive Director

Xaver started his career in finance in 2005 after obtaining a bachelor’s degree in Business Administration from the University of St.Gallen (HSG). At the beginning of his professional career, he worked with EY Switzerland as an auditor for industrial clients and graduated as a Swiss Certified Public Accountant in 2009. He later worked in various finance positions and led the global finance and accounting team of a listed Korean specialty chemical producer before joining HeiQ in 2018 as Head of Controlling. He was appointed Group Chief Financial Officer in October 2019.

Benjamin Bergo Non-Executive Director

Having joined the board on 30 June 2014, Ben brings a wealth of experience in high-growth technology operations and venture capital. He currently serves as President and CEO of Visus Therapeutics, Inc., an ophthalmic drug development company with offices in Seattle, WA, and Irvine, CA. He has previously served on the board of several high-growth companies, including as a non-executive director at Lumos Diagnostics Holdings Ltd (ASX:LDX), a leading full-service provider of point-of-care diagnostic solutions; as a non-executive director of Planet Innovation Holdings Limited, a healthtech innovation and commercialization company, and he led investments into life sciences transactions at a seed stage venture fund between 2007 and 2011. Prior to this, Ben held management roles at Vision BioSystems, until the sale of Vision Systems Limited to Danaher Corporation in 2006.

Karen Brade Non-Executive Director

Karen has extensive experience of project finance, private equity and asset management. She started her career at Citibank working on multi-national project finance transactions. Karen worked at CDC (Commonwealth Development Corporation), the UK Government’s development finance institution, where she held positions in equity and debt investing, portfolio management, fund raising and investor development. Karen has been an adviser to hedge funds, family offices and private equity houses. She currently serves as chairman of Aberdeen Japan Investment Trust plc; chairman of Keystone Positive Change Investment Trust plc; non-executive director and chair of audit at Augmentum Fintech plc and is an external panel member of the Albion Capital VCT investment committee.

Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.

HeiQ plc

Asset Match uses cookies to provide necessary site functionality and improve your experience. By using our website, you agree to our privacy policy and our cookie policy.

Asset Match uses cookies to provide necessary site functionality and improve your experience.
By using our website, you agree to our privacy policy and our cookie policy.